Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Suneva completes venture financing

    Suneva Medical Inc., San Diego, Calif. Business: Dermatology Date completed: 2015-07-29 Type: Venture financing Raised: $15 million Investor: Almirall

    Published on 8/3/2015
  • Suneva completes venture financing

    Suneva Medical Inc., San Diego, Calif. Business: Dermatology Date completed: 2015-07-29 Type: Venture financing Raised: $20.4 million Investor: Healthcare Royalty Partners Note: A portion of the proceeds of the term …

    Published on 8/3/2015
  • Theratechnologies completes follow-on

    Theratechnologies Inc. (TSX:TH), Montreal, Quebec Business: Endocrine/Metabolic, Pulmonary Date completed: 2015-07-23 Type: Follow-on Raised: C$9.6 million ($7.4 million) Units: 4 million Price: C$2.40 (unit) Shares …

    Published on 8/3/2015
  • vTv Therapeutics completes IPO

    vTv Therapeutics Inc. (NASDAQ:VTVT), High Point, N.C. Business: Neurology, Endocrine/Metabolic, Inflammation Date completed: 2015-07-30 Type: IPO Raised: $117.2 million Shares: 7.8 million Price: $15 Shares after …

    Published on 8/3/2015
  • Zogenix completes follow-on

    Zogenix Inc. (NASDAQ:ZGNX), San Diego, Calif. Business: Neurology Date completed: 2015-07-30 Type: Follow-on Raised: $85.5 million Shares: 4.8 million Price: $18 Shares after offering: 23.9 million Underwriters: Leerink…

    Published on 8/3/2015
  • Ally Bridge Group financial update

    Ally Bridge Group, Hong Kong, China Business: Finance Date announced: 2015-07-24 Note: Frank Yu, founder and CEO of Ally Bridge Group, and Bin Li, formerly the head of Asia healthcare equity research at Morgan Stanley, …

    Published on 8/3/2015
  • Aspyrian Therapeutics financial update

    Aspyrian Therapeutics Inc., San Diego, Calif. Business: Cancer, Antibodies Date announced: 2015-07-27 Note: Aspyrian raised $4.3 million in an extension of a series A round, bringing the total raised in the round to $12…

    Published on 8/3/2015
  • Capnia financial update

    Capnia Inc. (NASDAQ:CAPN), Redwood City, Calif. Business: Diagnostic Date announced: 2015-07-27 Note: Capnia entered into a two-year stock purchase agreement with Aspire Capital for up to $10 million.

    Published on 8/3/2015
  • CymaBay financial update

    CymaBay Therapeutics Inc. (NASDAQ:CBAY), Newark, Calif. Business: Endocrine/Metabolic Date announced: 2015-07-27 Note: CymaBay raised $3 million through the sale of 1.1 million shares at $2.81 to cover the overallotment…

    Published on 8/3/2015
  • Deerfield Management financial update

    Deerfield Management, New York, N.Y. Business: Finance Date announced: 2015-07-28 Note: Deerfield Management closed its Deerfield Healthcare Innovations Fund at $550 million. The fund will invest in early stage science …

    Published on 8/3/2015
  • Dynavax financial update

    Dynavax Technologies Corp. (NASDAQ:DVAX), Berkeley, Calif. Business: Inflammation, Infectious, Autoimmune Date announced: 2015-07-28 Note: Dynavax raised $18.7 million through the sale of 681,818 shares at $27.50 to …

    Published on 8/3/2015
  • Foresite Capital Management financial update

    Foresite Capital Management, San Francisco, Calif. Business: Finance Date announced: 2015-07-29 Note: Foresite Capital Management closed the Foresite Capital Fund III with $450 million. The firm said it will make …

    Published on 8/3/2015
  • Index Ventures financial update

    Index Ventures, Geneva, Switzerland Business: Finance Date announced: 2015-07-22 Note: Index Ventures raised EUR60 million ($66.5 million) for life science fund Index Ventures Life VII, according to an SEC filing.

    Published on 8/3/2015
  • Medigen Vaccine financial update

    Medigen Vaccine Biologics Corp., Taipei, Taiwan Business: Infectious Date announced: 2015-07-29 Note: Medigen Vaccine Biologics began the formal process to list on the Taipei Exchange in Taiwan by applying as an …

    Published on 8/3/2015
  • Pieris Pharmaceuticals financial update

    Pieris Pharmaceuticals Inc. (NASDAQ:PIRS), Freising-Weihenstephan, Germany Business: Autoimmune, Inflammation, Cancer Date announced: 2015-07-28 Note: Pieris raised $3.3 million through the sale of 1.2 million shares at…

    Published on 8/3/2015
  • Radius Health financial update

    Radius Health Inc. (NASDAQ:RDUS), Cambridge, Mass. Business: Musculoskeletal, Endocrine/Metabolic, Cancer Date announced: 2015-07-28 Note: Radius raised $45 million through the sale of 608,108 shares at $74 to cover the…

    Published on 8/3/2015
  • Body Organ Biomedical proposes IPO

    Body Organ Biomedical Corp. (TPEx-E:4177), Taipei, Taiwan Business: Ophthalmic, Dental, Supply/Service Date announced: 2015-07-22 Type: IPO To be raised: TBD Shares: TBD Price: TBD Underwriter: Jih Sun Securities Note: …

    Published on 8/3/2015
  • Erytech proposes follow-on

    Erytech Pharma S.A. (Euronext:ERYP), Lyon, France Business: Cancer, Endocrine/Metabolic, Hematology Date announced: 2015-07-28 Type: Follow-on To be raised: TBD Shares: TBD Price prior: EUR34.40 Note: Erytech is seeking…

    Published on 8/3/2015
  • Excelsior Biopharma proposes IPO

    Excelsior Biopharma Inc. (TPEx-E:6496), Taipei, Taiwan Business: Cardiovascular, Infectious, Gastrointestinal Date announced: 2015-07-28 Type: IPO To be raised: TBD Shares: TBD Price: TBD Underwriter: KGI Securities Co.…

    Published on 8/3/2015
  • AutoGenomics withdraws IPO

    AutoGenomics Inc., Vista, Calif. Business: Diagnostic, Microarrays Date announced: 2015-07-27 Type: IPO Underwriters: Stifel, Nicolaus; Canaccord; Cantor Fitzgerald Note: AutoGenomics withdrew its IPO on NASDAQ.

    Published on 8/3/2015
  • vTv Therapeutics amends IPO

    vTv Therapeutics Inc., High Point, N.C. Business: Neurology, Endocrine/Metabolic, Inflammation Date announced: 2015-07-20 Type: IPO To be raised: Up to $132.8 million Shares: 7.8 million Price: $15-$17 Underwriters: …

    Published on 7/27/2015
  • Zynerba amends IPO

    Zynerba Pharmaceuticals Inc., Radnor, Pa. Business: Autoimmune, Neurology, Drug delivery Date announced: 2015-07-23 Type: IPO To be raised: Up to $45 million Shares: 3 million Price: $13-$15 Underwriters: Jefferies; …

    Published on 7/27/2015
  • Blue Earth Diagnostics completes venture financing

    Blue Earth Diagnostics Ltd., London, U.K. Business: Diagnostic Date completed: 2015-07-23 Type: Venture financing Raised: L18 million ($28.1 million) Investor: Syncona Partners LLP

    Published on 7/27/2015
  • Cevec completes venture financing

    Cevec Pharmaceuticals GmbH, Cologne, Germany Business: Supply/Service, Biomanufacturing Date completed: 2015-07-22 Type: Venture financing Raised: EUR4.5 million ($4.9 million) Investors: Investtodate; Peppermint …

    Published on 7/27/2015
  • CytRx completes follow-on

    CytRx Corp. (NASDAQ:CYTR), Los Angeles, Calif. Business: Cancer Date completed: 2015-07-21 Type: Follow-on Raised: $25.1 million Shares: 9.1 million Price: $2.75 Shares after offering: 64.8 million Underwriters: …

    Published on 7/27/2015

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993